Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/25/2025

Diagnosing Insulin Resistance

Risk Assessment: Who Should Be Tested

  • The American Diabetes Association recommends testing for insulin resistance in patients with a BMI ≥25 kg/m² (or ≥23 kg/m² for Asian Americans) and additional risk factors 1, 2
  • Patients with a family history of type 2 diabetes, particularly those with a first-degree relative, should be tested for insulin resistance 1
  • Racial/ethnic predisposition, such as American Indian, African American, Hispanic/Latino, or Asian/Pacific Islander ancestry, increases the risk of insulin resistance 1, 2
  • Physical signs, including acanthosis nigricans, central/visceral adiposity, or skin tags, may indicate insulin resistance 1
  • Associated conditions, such as hypertension, dyslipidemia, polycystic ovary syndrome, or history of gestational diabetes, increase the risk of insulin resistance 1, 2
  • Lifestyle factors, including physical inactivity, contribute to the development of insulin resistance 2, 3

Diagnostic Testing Algorithm

  • Fasting plasma glucose (FPG) levels between 100-125 mg/dL indicate impaired fasting glucose and insulin resistance 1, 2
  • Fasting insulin levels >15 mU/L directly confirm insulin resistance 1
  • Hemoglobin A1C (HbA1c) levels between 5.7-6.4% suggest prediabetes with underlying insulin resistance 1, 2
  • Oral glucose tolerance test (OGTT) with 2-hour glucose levels between 140-199 mg/dL indicates impaired glucose tolerance and insulin resistance 1, 2

Comprehensive Clinical Evaluation

  • Physical examination should focus on signs of insulin resistance, including acanthosis nigricans, central obesity, and lipodystrophy 1, 3
  • Laboratory assessment should include lipid profile, checking for dyslipidemia (HDL <35 mg/dL, triglycerides >250 mg/dL) 1, 2
  • C-peptide measurement can help differentiate endogenous insulin production from exogenous administration 1

Interpreting Results

  • Presence of impaired fasting glucose (100-125 mg/dL) or impaired glucose tolerance (2-hour OGTT 140-199 mg/dL) indicates prediabetes and likely insulin resistance 1
  • Elevated fasting insulin (>15 mU/L) directly confirms insulin resistance 1
  • HbA1c levels >6.0% indicate high risk and require aggressive intervention 2

Critical Pitfalls to Avoid

  • Testing conditions should always be in a fasting state (minimum 8 hours) to avoid postprandial variations 1, 4
  • Normal glucose levels do not exclude insulin resistance, as hyperinsulinemia can exist with euglycemia 3
  • Isolated elevated C-peptide without hypoglycemia generally reflects insulin resistance rather than pathological hyperinsulinism 1

Population-Specific Considerations

  • Asian Americans have increased diabetes risk at lower BMI thresholds (≥23 kg/m² vs ≥25 kg/m²) 2, 4
  • African Americans may have equivalent diabetes risk at BMI 26 kg/m² compared to BMI 30 kg/m² in non-Hispanic whites 2

REFERENCES

1

Diagnosing Insulin Resistance [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Hyperinsulinemia Causes and Risk Factors [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Diagnosis of Type 2 Diabetes Mellitus [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025